Polysaccharides modulate immune responses by engaging pattern recognition receptors (PRRs) to induce T‐cell activation. In vaccine design, their particle size critically influences lymph node targeting and activation mechanisms. By engineering structural complexity and multivalent PRR engagement, polysaccharides enable precise modulation of immune ...
Jeong Hyun Moon +8 more
wiley +1 more source
A Phase 3 study to assess the safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in healthy infants in the USA and Puerto Rico. [PDF]
Campbell JD +10 more
europepmc +1 more source
Application of carbon nanotubes in cancer vaccines: Achievements, challenges and chances
Hatem A. F. M. Hassan +5 more
openalex +2 more sources
Eradicating infectious disease using weakly transmissible vaccines [PDF]
Scott L. Nuismer +5 more
openalex +1 more source
Wei et al. report that MPXV infection induces aerobic glycolysis, a process mediated by the viral protein I3 through lysine crotonylation at its K102 residue. The acetyltransferase MYST1 catalyzes the crotonylation of I3 to inhibit the ubiquitin‐mediated degradation of WDR26.
Pengjun Wei +12 more
wiley +1 more source
A review of vaccinology and <i>ex vivo</i> antigen-loaded dendritic cells: A different approach to infectious disease vaccines. [PDF]
Dillman RO, Nistor GI, Keirstead HS.
europepmc +1 more source
Edible Pneumatic Battery for Sustained and Repeated Robot Actuation
This work presents an edible energy source and valve system to power soft, pneumatically driven edible robots. A chemical reaction between sodium bicarbonate and citric acid generates carbon dioxide gas, and a pressure‐triggered edible valve enables self‐repetitive motion of the edible actuator.
Bokeon Kwak +5 more
wiley +1 more source
Publisher Correction: Modeling gonorrhea vaccination to find optimal targeting strategies that balance impact with cost-effectiveness. [PDF]
Leng T +3 more
europepmc +1 more source
MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-ASSOCIATED VACCINE PROTECTION FROM SIMIAN IMMUNODEFICIENCY VIRUS-INFECTED PERIPHERAL-BLOOD CELLS [PDF]
Boes, J +14 more
core +1 more source

